معرفی
Daniel W. Odell, MD is a Clinical Associate Professor in the Department of Anesthesiology at the University of Utah School of Medicine. He maintains dual clinical appointments at the University of Utah Health system and Huntsman Cancer Hospital, specializing in pain management and anesthesiology within the Supportive Oncology and Survivorship program. His practice focuses on complex cancer pain cases and advanced neuromodulation techniques, serving patients across Salt Lake City clinical sites including the Pain Management Center and Huntsman Cancer Institute South Clinic.
Dr. Odell's educational journey includes foundational training in biomedical engineering and microbiology, followed by medical education and specialized clinical training:
- Bachelor of Science in Biomedical Engineering (minor in Chemistry) from Utah State University
- Associate of Science in Microbiology from Brigham Young University-Idaho
- Doctor of Medicine from Medical College of Wisconsin
- Transitional Internship at Wheaton Franciscan – St. Joseph Campus
- Residency and Chief Residency in Anesthesiology at University of Utah School of Medicine
- Fellowship in Pain Medicine at University of Utah
His research program centers on revolutionizing cancer pain management through innovative intrathecal drug delivery systems, spinal cord stimulation, and evidence-based cannabis applications. Current investigations address critical gaps in understanding radiotherapy interactions with implanted pain devices, optimizing opioid-sparing protocols, and developing precision approaches for refractory cancer pain. This work directly informs his clinical practice where he implements cutting-edge neuromodulation strategies to minimize systemic opioid exposure while maximizing quality of life for oncology patients.
Analysis of his 15 most recent publications reveals a dominant research trajectory focused on intrathecal drug delivery optimization (60% of works), with significant contributions to neuromodulation techniques (25%) and cannabinoid therapeutics (10%). His scholarship demonstrates consistent methodological rigor through prospective case series, retrospective analyses, and systematic reviews that bridge basic science with clinical implementation. The publications collectively underscore a strategic shift toward reducing opioid dependence in cancer pain management while addressing device-related complications in irradiated tissues.
Dr. Odell maintains dual board certification from the American Board of Anesthesiology in both Anesthesiology and Pain Medicine subspecialty. His clinical excellence is reflected in exceptional patient satisfaction metrics (4.9/5 from 137 reviews), with consistent praise for his compassionate communication, technical expertise, and personalized approach to complex pain scenarios.
Within the University of Utah's academic ecosystem, Dr. Odell contributes to medical education through clinical supervision and has authored authoritative book chapters in The Hospice Companion. His collaborative work with multidisciplinary teams at Huntsman Cancer Institute integrates pain specialists, oncologists, and palliative care providers to develop comprehensive survivorship programs. Current initiatives focus on refining antiplatelet management protocols for cancer patients undergoing neuromodulation procedures and investigating wound healing implications of novel targeted therapies.
